Skip to main content
Top
Published in: Inflammation 2/2009

01-04-2009

Protective Roles of Hydroxyethyl Starch 130/0.4 in Intestinal Inflammatory Response and Oxidative Stress After Hemorrhagic Shock and Resuscitation in Rats

Authors: Pengfei Wang, Yousheng Li, Jieshou Li

Published in: Inflammation | Issue 2/2009

Login to get access

Abstract

This study was designed to determine the effects of various resuscitation fluids on intestinal injuries after hemorrhagic shock and resuscitation (HS/R) and to determine the potential mechanisms. We induced HS by bleeding male Sprague-Dawley rats to a blood pressure of 30 to 40 mmHg for 60 min. Sixty minutes later, the rats were killed (HS group) or immediately resuscitated with L-isomer lactated Ringer’s solution (HS + LR group), shed blood (HS + BL group), or hydroxyethyl starch (HS + HES group) to maintain the blood pressure to the original value during the 60-min resuscitation period. Three hour after resuscitation, bacterial translocation (BT), intestinal permeability, ileal levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, malondialdehyde (MDA), oxidized and reduced glutathione (GSH and GSSG), myeloperoxidase (MPO) activity, nuclear factor (NF)-κB, activator protein (AP)-1 activation, and ileal microscopic and ultrastructural histological changes were measured. Another experiment was designed for survival study of 24 h. HES 130/0.4 solution was as effective as shed blood, required a small volume requirement to restore circulation, and significantly reduced HS/R-induced ileal villous morphological injuries with an anti-inflammatory effect, as reflected by a reduction of TNF-α, IL-6, MPO activity, and NF-κB activation. In addition, HES resuscitation also reduced intestinal permeability and BT and caused less oxidative stress as reflected by a reduction of MDA, GSSG/GSH and AP-1 activation along with restored GSH, whereas shed blood couldn’t. No significant difference was observed in outcome among groups. HES 130/0.4 resuscitation prevents HS/R induced intestinal injury by modulating inflammatory response and preventing oxidative stress in a rat model of hemorrhagic shock. These physiological protective effects appear to be mediated by down-regulation of the transcription factor NF-κB and AP-1.
Literature
4.
go back to reference Imm, A., and R. W. Carlson. 1993. Fluid resuscitation in circulatory shock. Crit. Care. Clin. 9:313–333.PubMed Imm, A., and R. W. Carlson. 1993. Fluid resuscitation in circulatory shock. Crit. Care. Clin. 9:313–333.PubMed
5.
go back to reference Deitch, E. A., J. Morrison, R. Berg, and R. D. Specian. 1990. Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit. Care Med. 18:529 doi:10.1097/00003246-199005000-00014.PubMedCrossRef Deitch, E. A., J. Morrison, R. Berg, and R. D. Specian. 1990. Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit. Care Med. 18:529 doi:10.​1097/​00003246-199005000-00014.PubMedCrossRef
9.
go back to reference Jungheinrich, C., W. Sauermann, F. Bepperling, and N. H. Vogt. 2004. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study. Drugs R D. 5:1–9 doi:10.2165/00126839-200405010-00001.PubMedCrossRef Jungheinrich, C., W. Sauermann, F. Bepperling, and N. H. Vogt. 2004. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study. Drugs R D. 5:1–9 doi:10.​2165/​00126839-200405010-00001.PubMedCrossRef
10.
14.
go back to reference Chiu, C. J., A. H. McArdle, R. Brown, H. J. Scott, and F. N. Gurd. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch. Surg. 101(4):478–483.PubMed Chiu, C. J., A. H. McArdle, R. Brown, H. J. Scott, and F. N. Gurd. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch. Surg. 101(4):478–483.PubMed
16.
go back to reference Nemeth, I., and D. Boda. 1989. The ratio of oxidized/reduced glutathione as an index of oxidative stress in various experimental models of shock syndrome. Biomed. Biochim. Acta. 48:53–57. Nemeth, I., and D. Boda. 1989. The ratio of oxidized/reduced glutathione as an index of oxidative stress in various experimental models of shock syndrome. Biomed. Biochim. Acta. 48:53–57.
17.
go back to reference Schnoor, J., R. Schreck, J. H. Baumert, C. Grosse-Siestrup, R. Rossaint, and J. K. Unger. 2004. Influence of differences in body weight and volume management on experimental results in porcine models. Int. J. Artif. Organs. 27:924–934.PubMed Schnoor, J., R. Schreck, J. H. Baumert, C. Grosse-Siestrup, R. Rossaint, and J. K. Unger. 2004. Influence of differences in body weight and volume management on experimental results in porcine models. Int. J. Artif. Organs. 27:924–934.PubMed
21.
go back to reference Marx, G., M. Cobas Meyer, T. Schuerholz, B. Vangerow, K. F. Gratz, H. Hecker, R. Sumpelmann, H. Rueckoldt, and M. Leuwer. 2002. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med. 28:629–35 doi:10.1007/s00134-002-1260-3.PubMedCrossRef Marx, G., M. Cobas Meyer, T. Schuerholz, B. Vangerow, K. F. Gratz, H. Hecker, R. Sumpelmann, H. Rueckoldt, and M. Leuwer. 2002. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med. 28:629–35 doi:10.​1007/​s00134-002-1260-3.PubMedCrossRef
22.
go back to reference Taniguchi, T., Y. Koido, J. Aiboshi, T. Yamashita, S. Suzaki, and A. Kurokawa. 1999. The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am. J. Emerg. Med. 17:548–551 doi:10.1016/S0735-6757(99)90194-8.PubMedCrossRef Taniguchi, T., Y. Koido, J. Aiboshi, T. Yamashita, S. Suzaki, and A. Kurokawa. 1999. The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am. J. Emerg. Med. 17:548–551 doi:10.​1016/​S0735-6757(99)90194-8.PubMedCrossRef
23.
go back to reference Feng, X., J. Liu, M. Yu, S. Zhu, and J. Xu. 2007. Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and survival in rats challenged with polymicrobial sepsis. Clin. Chim. Acta. 376(1–2):60–67 doi:10.1016/j.cca.2006.07.008.PubMedCrossRef Feng, X., J. Liu, M. Yu, S. Zhu, and J. Xu. 2007. Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and survival in rats challenged with polymicrobial sepsis. Clin. Chim. Acta. 376(1–2):60–67 doi:10.​1016/​j.​cca.​2006.​07.​008.PubMedCrossRef
24.
go back to reference Fink, M. P. 2002. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer’s ethyl pyruvate solution. Curr. Opin. Clin. Nutr. Metab. Care. 5:167–174 doi:10.1097/00075197-200203000-00009.PubMedCrossRef Fink, M. P. 2002. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer’s ethyl pyruvate solution. Curr. Opin. Clin. Nutr. Metab. Care. 5:167–174 doi:10.​1097/​00075197-200203000-00009.PubMedCrossRef
25.
go back to reference Granger, D. N., J. N. Benoit, M. Suzuki, and M. B. Grisham. 1989. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am. J. Physiol. 257:683–688. Granger, D. N., J. N. Benoit, M. Suzuki, and M. B. Grisham. 1989. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am. J. Physiol. 257:683–688.
28.
go back to reference Therade-Matharan, S., E. Laemmel, J. Duranteau, and E. Vicaut. 2004. Reoxygenation after hypoxia and glucose depletion causes reactive oxygen species production by mitochondria in HUVEC. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287:1037–1043 doi:10.1152/ajpregu.00048.2004. Therade-Matharan, S., E. Laemmel, J. Duranteau, and E. Vicaut. 2004. Reoxygenation after hypoxia and glucose depletion causes reactive oxygen species production by mitochondria in HUVEC. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287:1037–1043 doi:10.​1152/​ajpregu.​00048.​2004.
29.
go back to reference Karabeyoğlu, M., B. Unal, B. Bozkurt, I. Dolapçi, A. Bilgihan, I. Karabeyoğlu, and O. Cengiz. 2008. The effect of ethyl pyruvate on oxidative stress in intestine and bacterial translocation after thermal injury. J. Surg. Res. 144(1):59–63 doi:10.1016/j.jss.2007.02.050.PubMedCrossRef Karabeyoğlu, M., B. Unal, B. Bozkurt, I. Dolapçi, A. Bilgihan, I. Karabeyoğlu, and O. Cengiz. 2008. The effect of ethyl pyruvate on oxidative stress in intestine and bacterial translocation after thermal injury. J. Surg. Res. 144(1):59–63 doi:10.​1016/​j.​jss.​2007.​02.​050.PubMedCrossRef
30.
go back to reference Mori, T., H. Yamamoto, T. Tabata, T. Shimizu, Y. Endo, K. Hanasawa, M. Fujimiya, and T. Tani. 2005. A free radical scavenger, edaravone (MCI-186), diminishes intestinal neutrophil lipid peroxidation and bacterial translocation in a rat hemorrhagic shock model. Crit. Care. Med. 33(5):1064–1069 doi:10.1097/01.CCM.0000162952.14590.EC.PubMedCrossRef Mori, T., H. Yamamoto, T. Tabata, T. Shimizu, Y. Endo, K. Hanasawa, M. Fujimiya, and T. Tani. 2005. A free radical scavenger, edaravone (MCI-186), diminishes intestinal neutrophil lipid peroxidation and bacterial translocation in a rat hemorrhagic shock model. Crit. Care. Med. 33(5):1064–1069 doi:10.​1097/​01.​CCM.​0000162952.​14590.​EC.PubMedCrossRef
31.
go back to reference Vega, D., C. D. Badami, F. J. Caputo, A. C. Watkins, Q. Lu, Z. Xu da, T. L. Berezina, S. B. Zaets, E. Feketeova, and E. A. Deitch. 2008. The influence of the type of resuscitation fluid on gut injury and distant organ injury in a rat model of trauma/hemorrhagic shock. J. Trauma. 65(2):409–414 discussion 414–5.PubMedCrossRef Vega, D., C. D. Badami, F. J. Caputo, A. C. Watkins, Q. Lu, Z. Xu da, T. L. Berezina, S. B. Zaets, E. Feketeova, and E. A. Deitch. 2008. The influence of the type of resuscitation fluid on gut injury and distant organ injury in a rat model of trauma/hemorrhagic shock. J. Trauma. 65(2):409–414 discussion 414–5.PubMedCrossRef
33.
go back to reference Paxian, M., I. Bauer, D. Kaplan, M. Bauer, and H. Rensing. 2002. Hepatic redox regulation of transcription factors activator protein-1 and nuclear factor-kB after hemorrhagic shock in vivo. Antioxid Redox Signal. 4(5):711–20 doi:10.1089/152308602760598855.PubMedCrossRef Paxian, M., I. Bauer, D. Kaplan, M. Bauer, and H. Rensing. 2002. Hepatic redox regulation of transcription factors activator protein-1 and nuclear factor-kB after hemorrhagic shock in vivo. Antioxid Redox Signal. 4(5):711–20 doi:10.​1089/​1523086027605988​55.PubMedCrossRef
35.
go back to reference Altavilla, D., A. Saitta, G. Squadrito, M. Galeano, S. F. Venuti, S. Guarini, C. Bazzani, A. Bertolini, A. P. Caputi, and F. Squadrito. 2002. Evidence for a role of nuclear factor-kB in acute hypovolemic hemorrhagic shock. Surgery. 131:50–58 doi:10.1067/msy.2002.118320.PubMedCrossRef Altavilla, D., A. Saitta, G. Squadrito, M. Galeano, S. F. Venuti, S. Guarini, C. Bazzani, A. Bertolini, A. P. Caputi, and F. Squadrito. 2002. Evidence for a role of nuclear factor-kB in acute hypovolemic hemorrhagic shock. Surgery. 131:50–58 doi:10.​1067/​msy.​2002.​118320.PubMedCrossRef
36.
37.
go back to reference Rensing, H., H. Jaeschke, I. Bauer, C. Pätau, V. Datene, B. H. Pannen, and M. Bauer. 2001. Differential activation pattern of redox-sensitive transcription factors and stress-inducible dilator systems heme oxygenase-1 and inducible nitric oxide synthase in hemorrhagic and endotoxic shock. Crit Care Med. 29(10):1962–1971 doi:10.1097/00003246-200110000-00019.PubMedCrossRef Rensing, H., H. Jaeschke, I. Bauer, C. Pätau, V. Datene, B. H. Pannen, and M. Bauer. 2001. Differential activation pattern of redox-sensitive transcription factors and stress-inducible dilator systems heme oxygenase-1 and inducible nitric oxide synthase in hemorrhagic and endotoxic shock. Crit Care Med. 29(10):1962–1971 doi:10.​1097/​00003246-200110000-00019.PubMedCrossRef
38.
go back to reference Domenicotti, C., D. Paola, A. Vitali, M. Nitti, C. D’Abramo, D. Cottalasso, G. Maloberti, F. Biasi, G. Poli, E. Chiarpotto, U. M. Marinari, and M. A. Pronzato. 2000. Glutathione depletion induces apoptosis of rat hepatocytes through activationof protein kinase C novel isoforms and dependent increase in AP-1 nuclear binding. Free Radic. Biol. Med. 29:1280–1290 doi:10.1016/S0891-5849(00)00429-9.PubMedCrossRef Domenicotti, C., D. Paola, A. Vitali, M. Nitti, C. D’Abramo, D. Cottalasso, G. Maloberti, F. Biasi, G. Poli, E. Chiarpotto, U. M. Marinari, and M. A. Pronzato. 2000. Glutathione depletion induces apoptosis of rat hepatocytes through activationof protein kinase C novel isoforms and dependent increase in AP-1 nuclear binding. Free Radic. Biol. Med. 29:1280–1290 doi:10.​1016/​S0891-5849(00)00429-9.PubMedCrossRef
Metadata
Title
Protective Roles of Hydroxyethyl Starch 130/0.4 in Intestinal Inflammatory Response and Oxidative Stress After Hemorrhagic Shock and Resuscitation in Rats
Authors
Pengfei Wang
Yousheng Li
Jieshou Li
Publication date
01-04-2009
Publisher
Springer US
Published in
Inflammation / Issue 2/2009
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-009-9105-7

Other articles of this Issue 2/2009

Inflammation 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine